Cancilico
Latest round
- Seed
Last raised
- Dec 2025
Total raised
- $2.9M
Investors
- 3
About Cancilico
Founded in 2023 in Dresden, Germany, Cancilico GmbH focuses on the development of AI-driven diagnostic tools.Cancilico specializes in AI-powered diagnostic solutions, with MyeloAID as its flagship product. MyeloAID automates the classification and counting of cells in bone marrow samples, leveraging advanced AI algorithms for rapid and precise analyses. It allows users to generate detailed myelograms in minutes, enhancing diagnostic accuracy and efficiency.Cancilico's revenue model is based on subscription services and partnerships with healthcare institutions and laboratories that require advanced diagnostic tools. Clients typically engage through contracts that integrate MyeloAID within their laboratory systems, allowing for scalable solutions tailored to various facility sizes. The company aims to launch new products in the coming year while targeting expansion into new geographic markets, including Asia and Latin America, by 2028.
Who invested in Cancilico
3 investors across 1 round
See all investors in Cancilico
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Dec 11, 2025
Amount
$2.9M
Investors
Questions about Cancilico
Who invested in Cancilico?
Cancilico has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cancilico raised?
Cancilico has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Cancilico last raise money?
Cancilico's most recent round on record is a Seed, in Dec 2025.
What does Cancilico do?
Founded in 2023 in Dresden, Germany, Cancilico GmbH focuses on the development of AI-driven diagnostic tools.
Where is Cancilico headquartered?
Cancilico is headquartered in Dresden, Germany.
Which VCs invest in companies like Cancilico?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Cancilico's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Cancilico? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.